Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on Reunion Health News.
Public Health Action Network Is A Partnering Organization for the 'Healthy Indoor Air' Event at the UN General Assembly
The Healthy Indoor Air event will bring together indoor air experts and policymakers from around the world. NEW YORK CITY, NY, UNITED STATES, September 22, 2025 /EINPresswire.com/ -- Public Health Action Network (PHAN), a nonprofit public health...
WHO cautions of increase of chikungunya disease
(MENAFN) The World Health Organization (WHO) cautioned on Tuesday that without swift measures, the world could face a repeat of the 2005 chikungunya outbreak. Diana Rojas Alvarez, WHO’s arbovirus team lead, revealed that the mosquito-borne virus...
Owner: Sawsan Dababneh & Ramzi AbdelJaber
Valneva Provides Update Following European Medicines Agency Announcement on Use of IXCHIQ® in Elderly
Saint Herblain (France), May, 07 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the European Medicines Agency (EMA) has started a review of Valneva’s single-dose live attenuated chikungunya...
Valneva Provides Update on Recommendation for Use of Its Chikungunya Vaccine by French Authorities
Saint Herblain (France), April 26, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that France’s national public health agency, the Haute Autorité de Santé (HAS), has updated its recommendation...
Valneva Responds to French Government’s Call for Vaccine Supply of IXCHIQ® against Chikungunya Outbreak in La Réunion
Saint Herblain (France), March 24, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it is responding to the chikungunya outbreak that is rapidly intensifying in France’s Island of La Réunion...
Deputy President Shipokosa Paulus Mashatile: Heritage Day 2025
Programme Directors, Minister of Sport, Arts, and Culture, Mr. Gayton McKenzie and Deputy Minister of Sport, Arts and Culture, Ms. Peace Mabe; Honourable Ministers and Deputy Ministers present here today; Members of Parliament and Provincial...
Owner: South African Government
OSE Immunotherapeutics Board Urges Support for Value-Driving Strategy and Open-Minded Governance - Publication of Circular for Combined Annual General Meeting of September 30, 2025
OSE Immunotherapeutics Board Urges Support for Value-Driving Strategy and Open-Minded Governance Publication of Circular for Combined Annual General Meeting of September 30, 2025 Nantes, September 9, 2025, 8:30 p.m. CET - OSE Immunotherapeutics SA...
Valneva Reports Half Year 2025 Financial Results and Provides Corporate Updates
Total revenues of €97.6 million compared to €70.8 million in the first half of 2024 Cash and cash equivalents of €161.3 million at end of June 2025 Further clinical and regulatory progress 2025 financial outlook confirmed Saint-Herblain (France),...
Statement on the Cabinet meeting of Wednesday, 17 September 2025
A. Issues in the environment 1. Economy 1.1. Economic Growth 1.1.1. Cabinet welcomed the latest GDP figures, which show that the economy has grown 0.8% in the second quarter of 2025, an improvement from the 0.1% growth in the first quarter. 1.1.2....
Owner: South African Government
Valneva Announces FDA’s Decision to Suspend License of Chikungunya Vaccine IXCHIQ® in the U.S.
Saint Herblain (France), August 25, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the United States Food and Drug Administration (FDA) has suspended the license for IXCHIQ®, citing four...
WHO cautions against increase of chikungunya illness
(MENAFN) The World Health Organization (WHO) has warned on Tuesday that without swift measures, the world risks facing a resurgence similar to the 2005 chikungunya outbreak. “Although chikungunya is not widely recognized, it is currently present...
Owner: Sawsan Dababneh & Ramzi AbdelJaber
WHO Cautions Chikungunya Spread Threatens Billions
(MENAFN) The World Health Organization (WHO) issued a stark warning Tuesday, cautioning that the world may be on the brink of reliving the devastating 2005 chikungunya epidemic unless swift containment measures are taken. "Chikungunya is not a...
Owner: Sawsan Dababneh & Ramzi AbdelJaber
Valneva Announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ® in Elderly and Updates to the Prescribing Information
Saint Herblain (France), August 7, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the FDA has removed its recommended pause in the use of IXCHIQ® in individuals 60 years of age and older...
Valneva Provides Update on Recommended Use of IXCHIQ® by Elderly Individuals in the United States
Saint Herblain (France), May, 12 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that the U.S. Food and Drug Association (FDA) and the U.S. Centers for Disease Control and Prevention (CDC), in a...
Valneva Reports Positive Six-Month Antibody Persistence and Safety Phase 2 Results in Children for its Single-Shot Chikungunya Vaccine IXCHIQ®
IXCHIQ® was well tolerated by children aged one to eleven years regardless of the dose or previous chikungunya infection (CHIKV) Antibody levels remained high after six months in both dose groups, although more robust with the full dose Six-month...
EU Balance of Payments and International Investment Position statistical sources and methods - B.o.p. and i.i.p. e-book
Introduction The European Central Bank (ECB), with the support of the European System of Central Bank’s (ESCB’s) Statistics Committee, compiles and publishes the balance of payments (b.o.p.) and the international investment position (i.i.p.) of...
Owner: European Union
Valneva Provides Update on ACIP Recommendation for its Chikungunya Vaccine IXCHIQ® Among U.S. Travelers
Saint Herblain (France), April 18, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that during its regular meeting on April 16, the U.S. Centers for Disease Control and Prevention’s (CDC)...
Valneva Submits Adolescent Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to UK MHRA
Saint Herblain (France), March 31, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that it has submitted a label extension application to the Medicines and Healthcare products Regulatory Agency...
Valneva’s Chikungunya Vaccine IXCHIQ® Now Authorized in EU for Adolescents Aged 12 and Above
With this extension, IXCHIQ®, the first vaccine against the chikungunya virus (CHIKV), is now available for administration for individuals 12 years of age and older in the European Union (EU). Saint Herblain (France), April 1, 2025 – Valneva SE...